Literature DB >> 19843935

Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression.

Verena Brucklacher-Waldert1, Karin Steinbach, Michael Lioznov, Manuela Kolster, Christoph Hölscher, Eva Tolosa.   

Abstract

Th17 cells are involved in the defense against bacteria and fungi and play a prominent role in the pathogenesis of autoimmune diseases, but research on human Th17 cells is hindered due to the lack of a surface marker. In this study, we report that a subset of human and mouse CD4(+) T cells as well as human Th17 T cell clones express IL-17A on their surface upon stimulation. Correlation of surface IL-17A expression with intracellular IL-17A production and with RORgammat mRNA expression identified surface IL-17A as a specific marker for human and mouse Th17 cells. Phenotype characterization of ex vivo CD4(+) IL-17A(+) cells showed that the chemokines CCR6 and CCR4, costimulatory molecules, as well as CD2 and CD49d were more prominently expressed on these cells than in surface IL-17A(-) cells, supporting the concept of Th17 cells as a potent inflammatory effector subtype. In addition, we generated human Th1, Th1/17 (producing both IFN-gamma and IL-17A), and Th17 T cell clones based on single cell sorting of surface IL-17A(-), IL-17A(int), and IL-17A(high) CD4(+) T cells, respectively, and showed the plasticity of the double producing clones to the cytokine milieu. The identification of surface IL-17A as a marker for Th17 cells should facilitate research on this subset.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843935     DOI: 10.4049/jimmunol.0901000

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Islet antigen-specific Th17 cells can induce TNF-α-dependent autoimmune diabetes.

Authors:  Cheng-Rui Li; Erin E Mueller; Linda M Bradley
Journal:  J Immunol       Date:  2014-01-20       Impact factor: 5.422

2.  Activation of T lymphocytes in atherosclerotic plaques.

Authors:  Jean-Charles Grivel; Oxana Ivanova; Natalia Pinegina; Paul S Blank; Alexander Shpektor; Leonid B Margolis; Elena Vasilieva
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-29       Impact factor: 8.311

3.  Molecular determinants of T cell epitope recognition to the common Timothy grass allergen.

Authors:  Carla Oseroff; John Sidney; Maya F Kotturi; Ravi Kolla; Rafeul Alam; David H Broide; Stephen I Wasserman; Daniela Weiskopf; Denise M McKinney; Jo L Chung; Arnd Petersen; Howard Grey; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

Review 4.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

5.  Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells.

Authors:  David M Kofler; Alexander Marson; Margarita Dominguez-Villar; Sheng Xiao; Vijay K Kuchroo; David A Hafler
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

6.  IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.

Authors:  Magdalena Huber; Sylvia Heink; Axel Pagenstecher; Katharina Reinhard; Josephine Ritter; Alexander Visekruna; Anna Guralnik; Nadine Bollig; Katharina Jeltsch; Christina Heinemann; Eva Wittmann; Thorsten Buch; Olivia Prazeres da Costa; Anne Brüstle; Dirk Brenner; Tak W Mak; Hans-Willi Mittrücker; Björn Tackenberg; Thomas Kamradt; Michael Lohoff
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

7.  Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.

Authors:  Kai Kisand; Anette S Bøe Wolff; Katarina Trebusak Podkrajsek; Liina Tserel; Maire Link; Kalle V Kisand; Elisabeth Ersvaer; Jaakko Perheentupa; Martina Moter Erichsen; Nina Bratanic; Antonella Meloni; Filomena Cetani; Roberto Perniola; Berrin Ergun-Longmire; Noel Maclaren; Kai J E Krohn; Mikulás Pura; Berthold Schalke; Philipp Ströbel; Maria Isabel Leite; Tadej Battelino; Eystein S Husebye; Pärt Peterson; Nick Willcox; Anthony Meager
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

8.  Report on the 1st scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Mittenwalde/Motzen, Germany, Oct. 30th - Nov. 1st, 2009.

Authors:  Tim Magnus; Ralf Linker; Sven G Meuth; Christoph Kleinschnitz; Thomas Korn
Journal:  Exp Transl Stroke Med       Date:  2010-03-31

9.  Mycobacterium tuberculosis multi-drug-resistant strain M induces IL-17+ IFNγ- CD4+ T cell expansion through an IL-23 and TGF-β-dependent mechanism in patients with MDR-TB tuberculosis.

Authors:  J I Basile; D Kviatcovsky; M M Romero; L Balboa; J Monteserin; V Ritacco; B Lopez; C Sabio y García; A García; M Vescovo; P G Montaner; D Palmero; M Del Carmen Sasiain; S de la Barrera
Journal:  Clin Exp Immunol       Date:  2016-11-02       Impact factor: 4.330

10.  The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label Phase I clinical trial.

Authors:  P C Rodríguez; D M Prada; E Moreno; L E Aira; C Molinero; A M López; J A Gómez; I M Hernández; J P Martínez; Y Reyes; J M Milera; M V Hernández; R Torres; Y Avila; Y Barrese; C Viada; E Montero; P Hernández
Journal:  Clin Exp Immunol       Date:  2017-11-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.